Well-differentiated papillary mesothelial tumour of the pleura Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

1 event

Dec 2007

Thyrogen: FDA approved

For use as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in patients who have undergone thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of metastatic thyroid cancer

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Well-differentiated papillary mesothelial tumour of the pleura.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Thyrogen

(Thyrotropin alfa)Orphan drug

Genzyme Corporation

Thyroid Stimulating Hormone [EPC]

12.1 Mechanism of Action Thyrotropin (TSH) is a pituitary hormone that stimulates the thyroid gland to produce thyroid hormone. Binding of thyrotropin...

Approved Dec 2007FDA label ↗

View full treatment details on disease page →